1. Home
  2. RAPT
  3. RAPT News

Latest RAPT Therapeutics Inc. (RAPT) News on January 19, 2025

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
RAPT

GlobeNewswire

10 days ago

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
RAPT

GlobeNewswire

13 days ago

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors

Rapt Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
RAPT

TipRanks

23 days ago

Rapt Therapeutics upgraded to Buy from Neutral at H.C. Wainwright

RAPT

MT Newswires

23 days ago

RAPT Therapeutics Shares Surge After HC Wainwright Upgrade

Progressive, EverQuote upgraded: Wall Street's top analyst calls
RAPT

The Fly

24 days ago

Progressive, EverQuote upgraded: Wall Street's top analyst calls

RAPT

MT Newswires

24 days ago

HC Wainwright Upgrades RAPT Therapeutics to Buy From Neutral, Price Target is $10

RAPT Therapeutics and Shanghai Jemincare sign anti-IgE antibody agreement
RAPT

Pharmaceutical Technology

a month ago

RAPT Therapeutics and Shanghai Jemincare sign anti-IgE antibody agreement

RAPT

MT Newswires

a month ago

Wells Fargo Raises RAPT Therapeutics' Price Target to $6 From $4, Overweight Rating Maintained

Why RAPT Therapeutics Stock Gained Over 100% On Monday?
RAPT

Benzinga

a month ago

Why RAPT Therapeutics Stock Gained Over 100% On Monday?

RAPT

MT Newswires

a month ago

RAPT Therapeutics, Shanghai Jemincare Sign Exclusive License Deal for Potential Food Allergy Treatment; Shares Up Pre-Bell

RAPT Therapeutics Announces $150 Million Private Placement
RAPT

GlobeNewswire

a month ago

RAPT Therapeutics Announces $150 Million Private Placement

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody
RAPT

GlobeNewswire

a month ago

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody

RAPT

MT Newswires

2 months ago

Stifel Nicolaus Downgrades RAPT Therapeutics to Hold From Buy, Cuts Price Target to $2 From $7

RAPT Therapeutics Reports Third Quarter 2024 Financial Results
RAPT

GlobeNewswire

2 months ago

RAPT Therapeutics Reports Third Quarter 2024 Financial Results

RAPT

MT Newswires

2 months ago

Top Midday Decliners

RAPT

MT Newswires

2 months ago

JPMorgan Downgrades RAPT Therapeutics to Underweight From Neutral; Shares Plunge

RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull
RAPT

Clinical Trials Arena

2 months ago

RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull

RAPT

MT Newswires

2 months ago

RAPT Therapeutics Ends Zelnecirnon Program After FDA Hold on Trials

Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury
RAPT

GlobeNewswire

2 months ago

Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury

Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky
RAPT

Simply Wall St.

2 months ago

Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky

RAPT Therapeutics, Inc. (RAPT): Worst 52-Week Low Stock to Buy Now
RAPT

Insider Monkey

4 months ago

RAPT Therapeutics, Inc. (RAPT): Worst 52-Week Low Stock to Buy Now

RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability
RAPT

Insider Monkey

4 months ago

RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability

RAPT Therapeutics Reports Second Quarter 2024 Financial Results
RAPT

GlobeNewswire

5 months ago

RAPT Therapeutics Reports Second Quarter 2024 Financial Results

RAPT

MT Newswires

6 months ago

RAPT Therapeutics to Cut 40% Workforce -- Shares Down

Should You Sell Your Stake in RAPT Therapeutics (RAPT)?
RAPT

Insider Monkey

7 months ago

Should You Sell Your Stake in RAPT Therapeutics (RAPT)?

Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround
RAPT

Zacks

7 months ago

Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround

Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
RAPT

Zacks

8 months ago

Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

RAPT

MT Newswires

8 months ago

Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform

Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks
RAPT

Zacks

8 months ago

Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks

Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
RAPT

Simply Wall St.

8 months ago

Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation

RAPT

GuruFocus.com

8 months ago

RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview

RAPT

MT Newswires

8 months ago

Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy

RAPT

MT Newswires

8 months ago

Barclays Downgrades RAPT Therapeutics to Equalweight, Price Target at $4

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
RAPT

Benzinga

8 months ago

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?

RAPT

MT Newswires

8 months ago

Sector Update: Health Care Stocks Higher Late Afternoon

RAPT

MT Newswires

8 months ago

RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials

RAPT Therapeutics Reports First Quarter 2024 Financial Results
RAPT

GlobeNewswire

8 months ago

RAPT Therapeutics Reports First Quarter 2024 Financial Results

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
RAPT

GlobeNewswire

9 months ago

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients

What Makes RAPT Therapeutics (RAPT) an Investment Choice?
RAPT

Insider Monkey

10 months ago

What Makes RAPT Therapeutics (RAPT) an Investment Choice?

Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings?
RAPT

Zacks

10 months ago

Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings?

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
RAPT

GlobeNewswire

10 months ago

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
RAPT

GlobeNewswire

10 months ago

RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting

Insider Buyers Lose Additional US$63k As RAPT Therapeutics Dips To US$236m
RAPT

Simply Wall St.

a year ago

Insider Buyers Lose Additional US$63k As RAPT Therapeutics Dips To US$236m

Rapt Therapeutics Crashes 74% After Unexpected Liver Failure Sidelines Two Tests
RAPT

Investor's Business Daily

a year ago

Rapt Therapeutics Crashes 74% After Unexpected Liver Failure Sidelines Two Tests

RAPT Therapeutics Stock Is Down 64%. FDA Halts 2 Studies After Liver Failure.
RAPT

Barrons.com

a year ago

RAPT Therapeutics Stock Is Down 64%. FDA Halts 2 Studies After Liver Failure.

RAPT

Reuters

a year ago

UPDATE 1-FDA puts on hold two Rapt Therapeutics mid-stage drug trials

RAPT

Reuters

a year ago

RAPT Therapeutics says FDA puts two mid-stage trials of company's drug on hold

RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
RAPT

GlobeNewswire

a year ago

RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon

FDA puts hold on Rapt trials of drug for eczema, asthma
RAPT

BioPharma Dive

a year ago

FDA puts hold on Rapt trials of drug for eczema, asthma

RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vice President of Technical Operations
RAPT

GlobeNewswire

a year ago

RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vice President of Technical Operations

RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
RAPT

GlobeNewswire

a year ago

RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Is It Too Late to Buy Tilray Brands Stock?
RAPT

Motley Fool

a year ago

Is It Too Late to Buy Tilray Brands Stock?

RAPT

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/30/2024

RAPT

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/29/2024

Johnson & Johnson Faces a 1.03% Portfolio Impact in Eaton Vance Worldwide Health Sciences ...
RAPT

GuruFocus.com

a year ago

Johnson & Johnson Faces a 1.03% Portfolio Impact in Eaton Vance Worldwide Health Sciences ...

Bel Fuse (BELFB) Declines More Than Market: Some Information for Investors
RAPT

Zacks

a year ago

Bel Fuse (BELFB) Declines More Than Market: Some Information for Investors

Can This $100 Billion Cybersecurity Stock Help You Retire a Millionaire?
RAPT

Motley Fool

a year ago

Can This $100 Billion Cybersecurity Stock Help You Retire a Millionaire?

RAPT

GuruFocus.com

a year ago

Hilltop Holdings Inc (HTH) Reports Mixed Financial Results for Q4 and Full Year 2023

RAPT

Associated Press Finance

a year ago

Hilltop Holdings: Q4 Earnings Snapshot

RAPT

Business Wire

a year ago

Hilltop Holdings Inc. Announces Financial Results for Fourth Quarter and Full Year 2023

Should Value Investors Buy Assurant (AIZ) Stock?
RAPT

Zacks

a year ago

Should Value Investors Buy Assurant (AIZ) Stock?

Kaplan Survey: Law Schools Concerned about Class Diversity, Amid Affirmative Action Ban Fallout
RAPT

Business Wire

a year ago

Kaplan Survey: Law Schools Concerned about Class Diversity, Amid Affirmative Action Ban Fallout

Eaton Vance Tax-mangd Glo Buy-write Oppo's Dividend Analysis
RAPT

GuruFocus.com

a year ago

Eaton Vance Tax-mangd Glo Buy-write Oppo's Dividend Analysis

Q3 Household Products Earnings Review: First Prize Goes to Clorox (NYSE:CLX)
RAPT

StockStory

a year ago

Q3 Household Products Earnings Review: First Prize Goes to Clorox (NYSE:CLX)

RAPT

Business Wire

a year ago

The New York Times Company to Announce Fourth-Quarter and Full-Year 2023 Financial Results on February 7, 2024

Bel Announces a New President of the Power and Protection Segment
RAPT

GlobeNewswire

a year ago

Bel Announces a New President of the Power and Protection Segment

Are Consumer Staples Stocks Lagging Coca-Cola Europacific Partners (CCEP) This Year?
RAPT

Zacks

a year ago

Are Consumer Staples Stocks Lagging Coca-Cola Europacific Partners (CCEP) This Year?

Canada Goose Stock (NYSE:GOOS): Benefit from Luxury Industry Panic
RAPT

TipRanks

a year ago

Canada Goose Stock (NYSE:GOOS): Benefit from Luxury Industry Panic

Strength Seen in Integer (ITGR): Can Its 3.8% Jump Turn into More Strength?
RAPT

Zacks

a year ago

Strength Seen in Integer (ITGR): Can Its 3.8% Jump Turn into More Strength?

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group
RAPT

Zacks

a year ago

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group

Caleres Reiterates Full Year 2023 Outlook
RAPT

Business Wire

a year ago

Caleres Reiterates Full Year 2023 Outlook

MercadoLibre (NASDAQ:MELI) Q3 Earnings: Leading The Online Marketplace Pack
RAPT

StockStory

a year ago

MercadoLibre (NASDAQ:MELI) Q3 Earnings: Leading The Online Marketplace Pack

RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
RAPT

GlobeNewswire

a year ago

RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

3 Charts For Investors to Watch Friday: Alphabet, Tesla, Altice USA
RAPT

Investopedia

a year ago

3 Charts For Investors to Watch Friday: Alphabet, Tesla, Altice USA

Here’s Why ZipRecruiter (ZIP) Declined in Q3
RAPT

Insider Monkey

a year ago

Here’s Why ZipRecruiter (ZIP) Declined in Q3

TELUS (TSE:T) shareholders have endured a 7.7% loss from investing in the stock a year ago
RAPT

Simply Wall St.

a year ago

TELUS (TSE:T) shareholders have endured a 7.7% loss from investing in the stock a year ago

OFG Bancorp (NYSE:OFG) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
RAPT

Simply Wall St.

a year ago

OFG Bancorp (NYSE:OFG) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Gogo Business Aviation's 5G Program Achieves Key Milestones
RAPT

PR Newswire

a year ago

Gogo Business Aviation's 5G Program Achieves Key Milestones

RLJ Lodging Trust Announces Dividends for Fourth Quarter of 2023
RAPT

Business Wire

a year ago

RLJ Lodging Trust Announces Dividends for Fourth Quarter of 2023

Ready Capital Corporation Declares Fourth Quarter 2023 Dividends
RAPT

GlobeNewswire

a year ago

Ready Capital Corporation Declares Fourth Quarter 2023 Dividends

Connection Achieves Microsoft Azure Expert MSP Renewal
RAPT

Business Wire

a year ago

Connection Achieves Microsoft Azure Expert MSP Renewal

Centerra Gold Inc.'s (TSE:CG) institutional investors lost 7.2% last week but have benefitted from longer-term gains
RAPT

Simply Wall St.

a year ago

Centerra Gold Inc.'s (TSE:CG) institutional investors lost 7.2% last week but have benefitted from longer-term gains

Lucid CFO resigns: Impact on stock, company outlook
RAPT

Yahoo Finance Video

a year ago

Lucid CFO resigns: Impact on stock, company outlook

Those who invested in AGCO (NYSE:AGCO) five years ago are up 145%
RAPT

Simply Wall St.

a year ago

Those who invested in AGCO (NYSE:AGCO) five years ago are up 145%

Oxford Industries, Inc. (NYSE:OXM) Q3 2023 Earnings Call Transcript
RAPT

Insider Monkey

a year ago

Oxford Industries, Inc. (NYSE:OXM) Q3 2023 Earnings Call Transcript

Adams Natural Resources Fund Announces $19.96 Issue Price of Shares for Year-End Distribution Payable December 15, 2023
RAPT

GlobeNewswire

a year ago

Adams Natural Resources Fund Announces $19.96 Issue Price of Shares for Year-End Distribution Payable December 15, 2023

Oman's BankDhofar is the First Bank in the Middle East to Install Diebold Nixdorf's RM4V Cash Recycling Engine to Deliver a World-Class Customer Experience
RAPT

PR Newswire

a year ago

Oman's BankDhofar is the First Bank in the Middle East to Install Diebold Nixdorf's RM4V Cash Recycling Engine to Deliver a World-Class Customer Experience

Should You Invest in Natural Resource Partners L.P. (NRP)?
RAPT

Insider Monkey

a year ago

Should You Invest in Natural Resource Partners L.P. (NRP)?

Capital Product Partners L.P. Announces Commencement of Rights Offering
RAPT

GlobeNewswire

a year ago

Capital Product Partners L.P. Announces Commencement of Rights Offering

RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Treat Atopic Dermatitis in Allergy
RAPT

GlobeNewswire

a year ago

RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Treat Atopic Dermatitis in Allergy

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
RAPT

InvestorPlace

a year ago

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare

RAPT Therapeutics Inc Reports Increased R&D Expenses Amid Progress in Clinical Trials
RAPT

GuruFocus.com

a year ago

RAPT Therapeutics Inc Reports Increased R&D Expenses Amid Progress in Clinical Trials

Capital Product Partners L.P. (NASDAQ:CPLP) Q3 2023 Earnings Call Transcript
RAPT

Insider Monkey

a year ago

Capital Product Partners L.P. (NASDAQ:CPLP) Q3 2023 Earnings Call Transcript

Vital Energy Promotes Katie Hill to Senior Vice President and Chief Operating Officer
RAPT

GlobeNewswire

a year ago

Vital Energy Promotes Katie Hill to Senior Vice President and Chief Operating Officer

Westrock Coffee Company to Participate in the Stephens Annual Investment Conference
RAPT

GlobeNewswire

a year ago

Westrock Coffee Company to Participate in the Stephens Annual Investment Conference

RAPT Therapeutics Reports Third Quarter 2023 Financial Results
RAPT

GlobeNewswire

a year ago

RAPT Therapeutics Reports Third Quarter 2023 Financial Results

TriNet Releases 2023 Environmental, Social and Governance Report
RAPT

PR Newswire

a year ago

TriNet Releases 2023 Environmental, Social and Governance Report

WK Kellogg Co Announces Third Quarter 2023 Financial Results and Reaffirms Financial Outlook
RAPT

PR Newswire

a year ago

WK Kellogg Co Announces Third Quarter 2023 Financial Results and Reaffirms Financial Outlook

TDCX Inc. to Report Third Quarter 2023 Results
RAPT

Business Wire

a year ago

TDCX Inc. to Report Third Quarter 2023 Results

RAPT

Thomson Reuters StreetEvents

a year ago

Q3 2023 Distribution Solutions Group Inc Earnings Call

Share on Social Networks: